- Home
- »
- Medical Devices
- »
-
Disposable Syringes Market Size, Share, Trends Report 2033GVR Report cover
Disposable Syringes Market (2026 - 2033)
Size, Share & Trends Analysis Report By Type (Conventional Syringes, Safety Syringes), By Application (Vaccines & Immunizations), By End-use (Hospital), By Region, And Forecasts
Market Size, 2025
$16.7BMarket Estimate, 2026
$17.7BMarket Forecast, 2033
$28.3BCAGR, 2026–2033
6.9%Disposable Syringes Market Summary
The global disposable syringes market size was valued at USD 16.7 billion in 2025 and is projected to grow from USD 17.7 billion in 2026 to USD 28.3 billion by 2033, growing at a CAGR of 6.9% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest global share of 31.4% in 2025. The growth can be attributed to the increasing incidence of chronic diseases and rising technological advancements.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,
Download Free Sample Report Key Market Trends & Insights
- By applications: Vaccines and immunizations segment led the market, accounting for 26.0% in 2025.
- By end-use: Hospital segment led the market, accounting for 34.3% of revenue in 2025.
Regional Highlights
- Largest regional market: Asia Pacific (31.4% revenue share, 2025)
- By country: China held the largest share of the Asia Pacific market in 2025
Market Size & Forecast
- Market size in 2025: USD 16.7 Billion
- Estimated market size in 2026: USD 17.7 Billion
- Projected market size by 2033: USD 28.3 Billion
- CAGR (2026-2033): 6.9%
Three ways to get this report
Buy it, customize it, or ask a question.Ask an Analyst
Analyst response in 1 business day
- AccessReport author, directly
- Reply timeWithin 1 working day
- No sales callDirect answer only
- FormatEmail reply
- CostFree, no cost
Get the Full Report
What the study covers
- FormatsPDF · Excel · Dashboard
- Timeline2026–2033 annual, 2025 base
- Coverage20+ countries, 5 regions
- Companies10+ key players profiled
Customize the Report
20% free customization
- IncludeCountries, segments, points
- TailorTo your product definition
- ExtendDeeper competitor detail
- OrA fully bespoke study
- Turnaround5–10 working days
Moreover, the growing adoption of safety syringes and the rising prevalence of diabetes are anticipated to drive market growth. According to the International Diabetes Federation (IDF), around 853 million individuals will have diabetes by 2050. Furthermore, supportive initiatives from manufacturers and the government to encourage the use of disposable syringes are anticipated to fuel the market growth in the coming years. For instance, in March 2024, Hindustan Syringes and Medical Devices, a manufacturer of auto-disable and disposable syringes, introduced the Dispojekt single-use syringe to protect against needlestick injuries.
To learn more about this report, Download Free Sample Report Moreover, the government of India has undertaken the manufacturing of disposable syringes, which is under development in Assam. This project costs around USD 0.63 million. Thus, the rising focus of the government on syringe manufacturing and growing expenditures for increasing syringe production are anticipated to boost the market growth over the forecast period.
In addition, reusing of syringes leads to the risk of contracting Hepatitis B, Hepatitis C, HIV, and many other blood-borne pathogens. The high burden of infectious diseases, such as HIV infection, which may be acquired via reused injectables among people, likely to increase the demand for disposable syringes. This, in turn, is anticipated to propel market growth over the forecast period. According to the study published by the National Library of Medicine in May 2023, the sharing of needles/syringes is positively associated with HIV infection. Hence, to prevent the spread of such infections, the adoption of disposable syringes is anticipated to increase, thus contributing to the market's growth.
To learn more about this report, Download Free Sample Report A high burden of HIV among adults and children can significantly increase the demand for disposable syringes. Reusing or sharing needles and syringes is a highly efficient way of HIV transmission. Among people who inject drugs, the risk of infection can be significantly reduced by consistently using new, disposable needles and syringes. As more individuals require treatments and other medical care involving injections, healthcare systems must ensure safe and hygienic practices. This growing need drives the expansion of disposable syringe production and distribution.
Furthermore, disposable syringes are used by patients with diabetes. Diabetic patients require insulin, and insulin syringes are disposable. Major companies such as BD and Hindustan Syringes & Medical Devices Ltd (HMD) offer single-use insulin syringes in various sizes. For instance, HMD offers two brands of single-use insulin syringes, i.e., DISPO VAN INSULIN SYRINGE and Single-use Insulin Syringes. The insulin syringes from manufacturers are also available with Luer-Lok tips to provide a locked connection quickly. Thus, with the rising prevalence of diabetes till 2050, the demand for single-use insulin syringes is anticipated to drive the market growth.
To learn more about this report, Download Free Sample Report Key Opinion Leaders
Company Name
KOLs
Growth Opportunities
Executive Director, Sohail Nath,
Hindustan Syringes and Medical Devices (HMD)
“HMD believes in delivering the best at the most competitive costing. Dispojekt safety needle syringes are going to be the game changer in the Global fight against NSIs. We are aiming to initially produce 200 million syringes and needles per annum, for which we have invested approximately Rs 70 crore (USD 8.15 million) in the first phase. In the second phase, we will increase the capacity to 300 million pieces per annum by investing another Rs 10 crore to Rs 15 crore (USD 1.75 million).”
- Rising Demand for Safety Syringes
- Expansion in Emerging Markets
Lee Woo Jun, the president of Hwajin Medical
"With the FDA's approval, our products, which focus on the domestic market, will be exported to the world, including the U.S., in the long term. As Hwajin’s Sofjec is also expected to be used for the COVID19 vaccine 'Nanocovax', which HLB has recently gained the global rights, its growth is likely to continue.”
- Regulatory Authorization
Lee Gwang-hee, Vice President of HLB Life Science's Medical Device Division.
"With this product approval, we can now fully enter the U.S. market. In the short term, we will generate profits through exports, and in the mid to long term, we aim to become the number one company in Korea's syringe industry."
- Entry into the U.S. Market
- Expansion of Market Share in Korea
- Leverage Regulatory Approval
Market DynamicsThe disposable syringes market is driven by the growing burden of chronic diseases such as diabetes, cancer, autoimmune disorders, and cardiovascular conditions that require frequent injectable therapies in hospitals, clinics, and home-care settings. Rising immunization and vaccination programs supported by governments and international health organizations continue to increase demand for single-use syringes, as they help prevent cross-contamination and improve patient safety. Healthcare providers are adopting disposable and safety-engineered syringes to reduce the risk of needlestick injuries and healthcare-associated infections, supported by stricter infection-control guidelines and occupational safety regulations. In addition, the expansion of healthcare infrastructure, rising hospital admissions, the growing use of biologic drugs, and the rising preference for self-administration of injectable medicines are further supporting market growth.
The rising prevalence of chronic diseases is a major driver of the disposable syringes market. Conditions such as diabetes, cancer, rheumatoid arthritis, cardiovascular disorders, and various autoimmune diseases require frequent administration of injectable medications, insulin, biologics, vaccines, or other therapeutic agents. As the number of patients living with these long-term conditions continues to rise, healthcare providers and patients rely on disposable syringes for safe and effective drug delivery. Disposable syringes help reduce the risk of infection and cross-contamination, making them the preferred choice in hospitals, clinics, and home care settings. In addition, the growing adoption of self-administered injectable therapies for chronic disease management has increased demand for easy-to-use, single-use syringes.
According to the data published by the American Diabetes Association in 2026, in 2023, over 40 million Americans, representing 12% of the population, were living with diabetes. More than 2 million Americans have type 1 diabetes, including approximately 314,000 children and adolescents. Of the 40.1 million people living with diabetes, 29.1 million have been diagnosed, while 11 million remain undiagnosed. Among Americans aged 65 and older, the prevalence of diabetes remains high at 28.8%. An estimated 1.5 million Americans are diagnosed with diabetes each year. In addition, more than 115 million Americans aged 18 and older are living with prediabetes.
Stringent regulations governing the manufacture of disposable syringes can restrain market growth by increasing compliance requirements and operational costs for manufacturers. Companies must adhere to standards covering product design, material quality, sterilization processes, manufacturing practices, labeling, packaging, and quality control to ensure patient safety and product reliability. Meeting these requirements requires significant investments in advanced manufacturing equipment, testing procedures, documentation, and regulatory approvals. Any changes in regulatory standards may require additional validation, audits, or product modifications, thereby delaying product launches and increasing development timelines. Smaller manufacturers may face challenges in maintaining compliance due to limited resources, while regulatory non-compliance can result in product recalls, penalties, or market access restrictions.
The development of eco-friendly, sustainable syringes presents a significant growth opportunity for the disposable syringes market, as healthcare providers, pharmaceutical companies, and governments focus on reducing the environmental impact of medical waste. Traditional disposable syringes are primarily made from petroleum-based plastics, which pose challenges for waste disposal and sustainability. In response, manufacturers are investing in biodegradable polymers, renewable materials, recyclable components, and low-carbon manufacturing processes to develop more environmentally responsible syringe solutions. Sustainable syringe innovations can help healthcare organizations meet environmental, social, and governance (ESG) objectives, comply with evolving environmental regulations, and reduce their carbon footprint. Recent developments such as bio-based syringe materials, recycling initiatives, and packaging designs that reduce plastic waste demonstrate the industry's shift toward greener products.
• January 2025 – SCHOTT Pharma launched the next generation of its SCHOTT TOPPAC infuse prefillable polymer syringe system in Mainz, Germany. The new system was designed to improve safety, efficiency, and sustainability in healthcare and was developed in collaboration with Schreiner MediPharm and Körber Pharma. The launch introduced a new syringe cap, a functional label, and carton-based secondary packaging. The cap provides a first-opening indication at the individual syringe level, helping to reduce medication waste and improve patient safety.
Market Concentration & Characteristics
The market growth stage is high, and the pace of growth is accelerating. The disposable syringes market is characterized by a high degree of growth owing to growing cases of chronic and infectious conditions and the increasing focus of manufacturers on expanding the manufacturing of disposable syringes.
Degree of Innovation: Innovation in disposable syringes is driven by safety and efficiency, with trends focusing on auto-disable mechanisms, retractable needles, and needle-stick injury prevention. Smart syringes with digital dose tracking and tamper-proof designs are anticipated to gain traction. Eco-friendly materials and sustainable manufacturing processes are also emerging, addressing environmental concerns while enhancing global health safety and compliance with evolving medical standards.
To learn more about this report, Download Free Sample Report Regulatory bodies such as the Food and Drug Administration (FDA) and other agencies set quality and safety standards for medical equipment, including disposable syringes. The authorities also issue warning documents for potentially hazardous products or for noncompliance with safety standards. For instance, in March 2024, the FDA warned about the unauthorized syringes from two Chinese distributors. Such instances can impact market growth.
Depending on the type of treatment, infusion pumps, transdermal patches, and oral or nasal drug delivery methods can be used as alternatives. These options may reduce infection risks, improve convenience, or enhance patient comfort in specific healthcare settings.
Manufacturers and companies operating in the industry are focusing on expanding their presence in numerous countries by gaining approvals from regulatory authorities. For instance, in August 2021, Hwajin Medical obtained U.S. market access for Sofjec through AMTC; Hwajin subsequently received direct U.S. FDA 510(k) clearance for Sofjec in February 2023. Such approvals and expansions are likely to boost market growth in the coming years.
Analyst Perspective
The disposable syringes market is witnessing substantial growth driven by the rising prevalence of chronic diseases, expanding vaccination programs, and increasing demand for safe injectable drug delivery worldwide. Market participants are emphasizing safety-engineered syringe technologies, automated manufacturing processes, and regulatory compliance to enhance patient safety, minimize needlestick injuries, and improve product quality. The shift from conventional disposable syringes toward advanced safety syringes and prefilled syringe systems is expected to support market revenue growth. In addition, the growing adoption of home-based healthcare, the increasing use of self-injection therapies, and the expansion of healthcare infrastructure across emerging economies are likely to strengthen market penetration further and create long-term growth opportunities.
Type Insights
Based on product, the safety syringes segment led the market with a 64.5% revenue share in 2025, and is expected to grow at the fastest CAGR over the forecast period. Safety syringes are needed for most therapeutic and diagnostic approaches for chronic disorders since they are crucial during medication administration and tests, resulting in a rising product demand. Companies are focusing on acquiring approvals for safety syringes and needles. For instance, in February 2023, Zephyrus Innovations, a manufacturer of medical devices, received the U.S. FDA approval for its Aeroject 3ml safety syringe. Thus, the rising approvals for safety syringes are anticipated to boost the segment demand in the coming years.
The conventional syringe segment is expected to grow significantly during the forecast period. Conventional syringes are the most commonly used syringes and are utilized in home care settings. For instance, conventional single-use syringes protect the patient receiving the injection. Moreover, the availability of conventional injectables from major industry participants such as BD is anticipated to drive the segment growth in the coming years.
Application Insights
By application, the vaccines and immunizations segment led the market, accounting for 26.0% of total revenue in 2025. The increasing adoption of disposable injectables for vaccination and immunization is anticipated to boost the segment growth in the coming years. Manufacturers have supplied many syringes to strengthen the vaccination drive during the COVID-19 pandemic. For instance, an article published by the Indian Pharma Post in June 2023 reported that Hindustan Syringes & Medical Devices Ltd (HMD) provided 1.75 billion syringes out of the 13.3 billion COVID-19 vaccines administered globally. This means that over 13% of COVID-19 shots worldwide were given using HMD's Kojak Selinge Auto Disable (AD) Syringes, equating to nearly 1 in every 7-8 people receiving their vaccine through HMD's syringe. Such an increase in the supply of disposable injectables for vaccination is anticipated to propel the segment growth in the coming years.
The oncology segment is expected to grow at the fastest CAGR over the forecast period. The growth of the oncology segment can be attributed to the rising prevalence of cancer across the globe, coupled with the growing need for diagnosis and treatment of this deadly disease. According to the Union for International Cancer Control (UICC), around 10 million individuals die each year from cancer. Moreover, as per the article published by the WHO in February 2024, more than 35 million new cancer patients are forecasted in 2050, with a 77% growth from the evaluated 20 million cases in 2022. Thus, the large number of individuals who have cancer is anticipated to propel the segment growth in the coming years.
End Use Insights
By end use, the hospital segment led the market, accounting for 34.3% of revenue in 2025. Patients prefer hospitals for treatment due to their established trust and convenient accessibility. Hospitals also offer fluid therapy, which administers fluids to patients’ bodies subcutaneously or intravenously. As a result, the demand for injectable medicines and disposable syringes in hospitals continues to rise. Therefore, the demand for syringes in hospitals continues to rise.
To learn more about this report, Download Free Sample Report The pharmaceutical segment is expected to grow at the fastest CAGR over the forecast period. The segment is supported by the increasing use of disposable syringes for drug administration across pharmaceutical and biopharmaceutical applications. Meanwhile, the other segment, which includes ambulatory surgery centers, academic and medical research centers, and defense forces, is also expected to witness growth. A growing shift toward ambulatory surgery centers is anticipated to support demand for disposable syringes, while rising healthcare expenditures and increasing investments in research and medical facilities are expected to further contribute to segment growth.
Regional Insights
North America disposable syringes market is anticipated to witness significant growth, propelled by a combination of factors such as technological advancements, the rising prevalence of chronic diseases, and government initiatives. According to the statistics published by the U.S. Department of Health and Human Services in January 2024, around 38.4 million people of all ages had diabetes in the U.S. in 2021. Thus, many individuals suffering from chronic diseases are anticipated to drive the regional market growth.
U.S. Disposable Syringes Market Trends
The disposable syringes market in the U.S. is anticipated to dominate the North American market over the forecast period. The presence of major players and rising FDA approvals for disposable syringes are anticipated to support the market growth. Moreover, the rising demand for injectable drugs across the country is expected to fuel the country's market in the coming years.
Europe Disposable Syringes Market Trends
The disposable syringes market in Europe is anticipated to grow significantly over the forecast period. This growth can be attributed to the increased healthcare spending and the rising prevalence of chronic diseases such as diabetes and cancer, which require frequent injections. Heightened safety awareness and regulations to prevent needle-stick injuries are also driving demand for single-use syringes. Additionally, widespread vaccination campaigns, including initiatives such as European Immunization Week observed in May 2025, further support market growth by emphasizing the importance of vaccinations in preventing infectious diseases.
The disposable syringes market in the UK is expected to grow substantially during the forecast period. This growth is driven by several key factors, including an aging population and an increasing burden of chronic disorders, which heighten the demand for disposable syringes. Additionally, there is a growing emphasis on infection prevention, supported by stringent regulations and increased safety awareness, which is likely to boost the adoption of single-use syringes.
France disposable syringes market is expected to grow over the forecast period, owing to high healthcare expenditures and the increasing prevalence of chronic conditions. For instance, according to a study published by ScienceDirect in March 2024, in France, around nine out of 10 deaths are caused by non-communicable disorders.
The disposable syringes market in Germany is witnessing steady growth owing to industry participants' rising focus on expanding their presence in Germany and increasing vaccination campaigns. For instance, in September 2023, Germany introduced its autumn vaccination campaign to avert respiratory infections, promoting an updated COVID-19 booster shot for the elderly and high-risk individuals. Strict safety regulations and the aging population further contribute to market growth, especially for injections and disease management.
Asia Pacific Disposable Syringes Market Trends
Asia Pacific dominated the disposable syringes market, accounting for the largest revenue share of 31.4% in 2025. Asia Pacific region held the largest revenue share of the disposable syringes market. This dominance is driven by several key factors, such as the increasing prevalence of chronic diseases, including diabetes and infectious diseases, among the region's population. For instance, according to the article published by Health Equity Matters in November 2023, there were 28,870 people with HIV in Australia in 2022. Thus, numerous individuals suffering from infectious diseases are anticipated to boost the demand for disposable syringes and needles across the Asia Pacific region.
To learn more about this report, Download Free Sample Report The disposable syringes market in China is expected to grow due to increasing healthcare investments, a rising prevalence of chronic diseases like diabetes, and extensive vaccination campaigns. The aging population and stricter safety regulations are also anticipated to drive sustained disposable syringe demand.
The India disposable syringes market was the second-largest market in Asia Pacific in 2025. India's disposable syringes market is propelled by factors such as the country’s rising burden of chronic conditions, increasing launches of disposable syringes and needles, and a growing emphasis by major industry players on the country's market. Companies operating in the country are increasing investments to strengthen their presence in India.
“We aim for 60-70 per cent market share in the next three years due to our innovative Dispojekt. We are aiming to initially produce 200 million syringes and needles per annum for which we have invested Rs 70 crore (USD 8.15 million) in the first phase.”-Hindustan Syringes and Medical Devices (HMD), Executive Director
Latin America Disposable Syringes Market Trends
The disposable syringes market in Latin America is expected to experience strong growth over the forecast period, driven by growing healthcare infrastructure and the increasing burden of chronic diseases. The region’s aging population requires more injectable treatments, while stricter safety regulations and heightened health awareness encourage the shift toward single-use syringes, boosting market demand and growth.
Middle East and Africa Disposable Syringes Market Trends
The Middle East and Africa disposable syringes market is expected to register the fastest growth over the forecast period due to the rising prevalence of chronic diseases such as diabetes. According to statistics published by the International Diabetes Federation in May 2025, approximately 1,274,200 cases of diabetes in adults were reported in the UAE in 2024.
The disposable syringe market in Saudi Arabia is driven by increasing healthcare investments that are aligned with the Saudi Vision 2030 initiative, which aims to enhance the healthcare sector. Rising chronic diseases such as diabetes, an aging population, and large-scale vaccination initiatives also contribute to demand.
Key Disposable Syringes Company Insights
Hindustan Syringes & Medical Devices Ltd, NIPRO, B. Braun SE, BD, Cardinal Health, Vita Needle Company, Terumo Europe NV, Ulti Med Products, SMB Corporation of India, Henke Sass Wolf GmbH, Cartel Health Care Pvt. Ltd¸Hi-Tech Syringes, VEM Tooling Co., Ltd. (VEM Thailand Co. Ltd), APEX MEDICAL DEVICES, JMS Co., Ltd., OSAKA CHEMICAL Co.,Ltd, Lifelong Meditech Private Limited, Liaoning Kangyi Medical Equipment Co., Ltd, kohope.com, and Retractable Technologies, Inc. are some of the major players in the disposable syringes market. Companies in the industry are introducing innovative products and expanding their manufacturing capacities to strengthen their market presence. Additionally, manufacturers are investing significantly in disposable injectables to enhance global distribution and meet growing international demand.
Key Disposable Syringes Companies
The following key companies have been profiled for this study on the disposable syringes market.
-
Hindustan Syringes & Medical Devices Ltd
-
NIPRO
-
B. Braun SE
-
BD
-
Cardinal Health
-
Vita Needle Company
-
Terumo Europe NV
-
ulti med Products
-
Henke-Sass Wolf GmbH
-
Retractable Technologies, Inc.
-
kohope.com
-
Liaoning Kangyi Medical Equipment Co., Ltd.
-
SMB Corporation of India
-
Lifelong Meditech Private Limited
-
OSAKA CHEMICAL Co., Ltd.
-
JMS Co., Ltd
-
APEX MEDICAL DEVICES
-
Cartel Health Care Pvt. Ltd
-
Hi-Tech Syringes
-
VEM Tooling Co., Ltd. (VEM Thailand Co., Ltd.)
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Hindustan Syringes & Medical Devices Ltd, NIPRO, B.Braun SE, BD, Cardinal Health, Vita Needle Company, Terumo Europe NV, ulti med Products, Henke Sass Wolf GmbH)
- Expand global manufacturing capacity while maintaining strict regulatory compliance, ensuring uninterrupted supply, cost efficiency, and consistent product quality across healthcare markets.
- Invest continuously in safety-engineered syringes, automation, and strategic partnerships with hospitals and distributors to strengthen long-term customer relationships and market presence.
- Strong global brand recognition, extensive distribution networks, and comprehensive product portfolios enable reliable supply and customer trust across diverse healthcare settings.
- Advanced manufacturing technologies, regulatory expertise, and large-scale production capabilities support premium product quality, competitive pricing, and rapid response to market demand.
- Large organizational structures and complex global operations can delay decision-making, product innovation, and rapid adaptation to changing regional market requirements.
- High manufacturing, compliance, and operational costs reduce pricing flexibility, creating challenges when competing against low-cost regional and domestic manufacturers.
Emerging Players (Kohope Medical/Shanghai Kohope Medical Devices Co., Ltd., Liaoning Kangyi Medical Equipment Co., Ltd., SMB Corporation of India, Lifelong Meditech Private Limited, APEX Medical Devices, Cartel Health Care Pvt. Ltd., Hi-Tech Syringes)
- Focus on cost-efficient manufacturing and on expanding regional distribution to increase market penetration and compete effectively with established multinational suppliers.
- Develop OEM partnerships and private-label production capabilities while gradually obtaining international regulatory certifications to support future export growth.
- Lower production costs and operational flexibility enable faster customization of syringe products to meet local healthcare customer requirements.
- Agile management structures enable quicker market entry, faster product modifications, and responsive customer service across developing healthcare markets.
- Limited global brand recognition and smaller distribution networks restrict access to large hospital contracts and international procurement programs.
- Limited financial resources and small-scale manufacturing can constrain research investments, regulatory expansion, and resilience during market disruptions.
Recent Developments
-
In June 2025, the Indian government exempted high-density polyethylene (HDPE), a raw material for disposable syringes, from mandatory Bureau of Indian Standards (BIS) quality certification to streamline production and support medical device manufacturing.
-
In January 2024, medmix Drug Delivery introduced SicuroJect, a disposable passive needle safety device at Pharmapack Europe in Paris, to expand its product portfolio.
-
In May 2023, Hindustan Syringes & Medical Devices Ltd (HMD), a manufacturer of auto-disable and disposable injectables, reached the milestone of supplying 1.75 billion syringes of the entire 13.3 billion COVID-19 vaccines administered worldwide. The company has supplied about 650 million AD and disposable syringes to UNICEF.
-
In February 2023, Zephyrus Innovations, a manufacturer of medical devices, received the U.S. FDA approval for its Aeroject 3ml safety syringe.
Disposable Syringes Market Report Scope
Report Attribute
Details
Market size value in 2025
USD 16.7 billion
Market size value in 2026
USD 17.7 billion
Revenue forecast in 2033
USD 28.3 billion
Growth rate
CAGR of 6.9% from 2026 to 2033
Historical data
2021 - 2024
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million/billion, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Type, application, end-use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
Hindustan Syringes & Medical Devices Ltd, NIPRO, B. Braun SE, BD, Cardinal Health, Vita Needle Company, Terumo Europe NV, ulti med Products, Henke-Sass Wolf GmbH, Retractable Technologies, Inc., kohope.com, Liaoning Kangyi Medical Equipment Co., Ltd, SMB Corporation of India, Lifelong Meditech Private Limited, OSAKA CHEMICAL Co., Ltd., JMS Co., Ltd, APEX MEDICAL DEVICES, Cartel Health Care Pvt. Ltd., Hi-Tech Syringes, VEM Tooling Co., Ltd. (VEM Thailand Co., Ltd.)
Customization scope
Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Disposable Syringes Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global disposable syringes market report based on type, application, end use, and region:
To learn more about this report, Download Free Sample Report -
Type Outlook (Revenue, USD Million, 2021 - 2033)
-
Conventional Syringes
-
Safety Syringes
-
Retractable Safety Syringes
-
Non-retractable Safety Syringes
-
-
-
Application Outlook (Revenue, USD Million, 2021 - 2033)
-
Vaccines and immunizations
-
Anaphylaxis
-
Rheumatoid Arthritis
-
Diabetes
-
Autoimmune diseases
-
Oncology
-
Others
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Hospital
-
Diagnostic Laboratories
-
Blood Banks
-
Pharmaceutical Industry
-
Veterinary purposes
-
Others
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Research Methodology
The disposable syringes market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each disposable syringes segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment – Type
Revenue capture definition
Conventional Syringes
This segment captures global revenue generated from the standard, non-mechanism disposable syringes used for routine fluid administration or aspiration. It includes both luer-lock and luer-slip variants across various sizes, specifically tracking sales to hospitals, clinics, and home care settings while excluding integrated needle safety features.
Safety Syringes
Market revenue for this category reflects the total sales of specialized disposable syringes engineered with built-in injury-prevention mechanisms. It encompasses retractable needles, sliding shields, and auto-disable technologies designed to protect healthcare workers from needlestick injuries, capturing premium pricing across medical facilities and safety-mandated regions.
Estimation Model
Layer No.
Layer Name
Key Question
Description
01
Bottom-Up Epidemiological Modeling
What is the total syringe demand based on the target patient population?
Estimating the target patient population requiring injections across therapeutic areas (diabetes, oncology, vaccines, immunology, pain management, critical care, etc.) using epidemiological data and trends. Applies average syringes used per patient per year based on treatment protocols, route of administration, and therapy duration to derive total syringe demand.
02
Top-Down Revenue Triangulation
What is the disposable syringes market revenue based on manufacturer and supplier revenues?
Analyzing total revenue reported by key disposable syringe manufacturers and suppliers globally and regionally, and allocating revenues to the disposable syringes segment based on product mix (syringes vs. other medical disposables), pricing bands, and geographic sales split.
03
Demand-Side Care-Setting Modeling
What is the market size based on injection volumes across care settings?
Assessing procedure and injection volumes across care settings (hospitals, clinics, home care, ambulatory surgical centers, and long-term care) and applying syringe type mix (standard, safety, insulin, tuberculin, prefilled, etc.) and average selling price to estimate market size.
04
Supply-Side Capacity & Utilization Modeling
What supply can be achieved based on manufacturing capacity and utilization?
Evaluating global and regional manufacturing capacity, production output, capacity utilization rates, raw material availability (PP, rubber, silicone), supply chain dynamics, and export-import flows to assess achievable supply and reconcile demand-supply gaps.
05
Data Triangulation & Market Reconciliation
How are market estimates validated and reconciled?
Synthesizing outputs from multiple models (bottom-up, top-down, demand-side, and supply-side) using primary research, company filings, trade data, and expert insights to validate assumptions, resolve variances, and finalize market size estimates.
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
ASP and volume analysis (historical and forecast)
Comprehensive ASP (Average Selling Price) and volume analysis for disposable syringes across 2021–2033, segmented by type (conventional, safety), application, end use, and geography. Includes historical pricing trends, procurement models, utilization rates, public immunization demand, and long-term forecasts based on injection volumes, healthcare expenditure, and adoption of safety-engineered syringes.
Enables long-term revenue forecasting, pricing strategy optimization, procurement planning, identification of premium product opportunities, evaluation of regional demand trends, and investment decision-making across mature and emerging healthcare markets.
Procedure volume and patient population analysis
Detailed assessment of disposable syringe demand across hospitals, clinics, ambulatory surgical centers, diagnostic laboratories, blood banks, pharmacies, vaccination centers, and home healthcare. Includes segmentation by therapeutic application (vaccination, insulin delivery, drug administration, blood collection), injection frequency, patient population, and syringe utilization rates across developed and emerging markets.
Supports accurate demand forecasting, identification of high-growth therapeutic applications, healthcare resource planning, capacity optimization, and targeted commercial strategies based on end-user purchasing behavior and procedure volumes.
Competitive benchmarking and market share analysis
Comprehensive evaluation of leading disposable syringe manufacturers, including product portfolio benchmarking, pricing comparison, regional market share, manufacturing capacity, distribution network assessment, regulatory approvals (FDA, CE, ISO), sustainability initiatives, technology adoption (safety syringes), strategic partnerships, acquisitions, and new product launches across major markets.
Enables competitive positioning, identification of market gaps, pricing optimization, partnership and acquisition evaluation, product differentiation, portfolio expansion planning, and strategic decision-making for regional and global market growth.
Frequently Asked Questions About This Report
The global disposable syringes market size was valued at USD 16.7 billion in 2025 and is estimated at USD 17.7 billion in 2026.
The global disposable syringes market is expected to grow at a compound annual growth rate of 6.9% from 2026 to 2033, reaching USD 28.3 billion by 2033.
Asia Pacific dominated the disposable syringes market, accounting for 31.4% in 2025. This is attributable to the high prevalence of diseases and increasing preference for injectable drugs.
Some key players operating in the disposable syringes market include Hindustan Syringes & Medical Devices Ltd, NIPRO, B. Braun SE, BD, Cardinal Health, Vita Needle Company, Terumo Europe NV, ulti med Products, Henke-Sass Wolf GmbH, Retractable Technologies, Inc., kohope.com, Liaoning Kangyi Medical Equipment Co., Ltd, SMB Corporation of India, Lifelong Meditech Private Limited, OSAKA CHEMICAL Co., Ltd., JMS Co., Ltd, APEX MEDICAL DEVICES, Cartel Health Care Pvt. Ltd., Hi-Tech Syringes, and VEM Tooling Co., Ltd. (VEM Thailand Co., Ltd.).
MEA is the fastest-growing region over the forecast period.
The safety syringes segment led with a 64.5% revenue share in 2025, and it is the fastest-growing segment.
The vaccines and immunizations segment led with a 26.0% revenue share in 2025, and oncology is the fastest-growing segment.
The hospital segment led with a 34.3% revenue share in 2025, and the pharmaceutical industry is the fastest-growing segment.
Key factors that are driving the disposable syringes market growth. The disposable syringes market is driven by rising vaccination programs, increasing prevalence of chronic and infectious diseases, growing demand for injectable therapies, expanding healthcare infrastructure, stronger infection prevention practices, adoption of safety-engineered syringes, and increasing surgical procedures supported by favorable government healthcare initiatives.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
